Compare VVOS & NXGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VVOS | NXGL |
|---|---|---|
| Founded | 2016 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.7M | 15.0M |
| IPO Year | 2020 | 2021 |
| Metric | VVOS | NXGL |
|---|---|---|
| Price | $2.26 | $1.70 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $6.25 | N/A |
| AVG Volume (30 Days) | ★ 129.8K | 77.8K |
| Earning Date | 11-19-2025 | 11-11-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $17,317,000.00 | $11,666,000.00 |
| Revenue This Year | $17.96 | $39.28 |
| Revenue Next Year | $55.64 | $42.29 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 18.76 | ★ 73.37 |
| 52 Week Low | $1.93 | $1.45 |
| 52 Week High | $7.95 | $4.00 |
| Indicator | VVOS | NXGL |
|---|---|---|
| Relative Strength Index (RSI) | 51.67 | 49.77 |
| Support Level | $1.94 | $1.46 |
| Resistance Level | $2.69 | $1.90 |
| Average True Range (ATR) | 0.14 | 0.14 |
| MACD | 0.06 | 0.04 |
| Stochastic Oscillator | 41.18 | 54.55 |
Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.
NexGel Inc manufactures high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company specializes in custom gels by capitalizing on proprietary manufacturing technologies. The gels and consumer products are manufactured using proprietary and non-proprietary mixing, coating and cross-linking technologies.